ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Harold Douglass New GITSG Chairman: NTP Deputy Chief Moore to Be Nominated For Top EPA Position

August 5, 1983

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

NCI Grant To Help Pitt Include Teaching End-of-Life Issues.

July 6, 2001

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008